Exercise Price Determined for the Exercise of Warrants Series TO 14 in Alligator Bioscience AB

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH ...
Morningstar

Alligator Bioscience AB Announces Final Outcome of Exercise of Warrants Series TO 13

The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") (the "Warrant Programme"), issued in connection with the Company's rights ...
Morningstar

Alligator Bioscience AB Announces Preliminary Outcome of Exercise of Warrants Series TO 13

The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 15 September 2025. The preliminary outcome indicates that a total ...